Conceptually similar

CP123328571 | B.C. reports 2nd case of vaccine-induced condition

CP122904771 | B.C. records first case of rare blood clot related to vaccine

CP120124021 | AstraZeneca COVID-19 vaccine now recommended for Canadian seniors

CP119565630 | What to know about Johnson & Johnson's COVID-19 vaccine

CP123183671 | L'Alberta cesse d'utiliser le vaccin d'AstraZeneca

CP120121621 | AstraZeneca recommandé pour les 65 ans et plus

CP119568721 | Here's what to know about Johnson & Johnson's COVID-19 vaccine

CP122830710 | New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine

CP121635062 | AstraZeneca vaccine to remain authorized in Canada

CP123251321 | Ontario to get more than 250,000 AstraZeneca doses

Placeline/People

City Vaughan

Country Canada

What to do if you think you have rare case of VITT

Vaccine-induced thrombotic thrombocytopenia, or VITT, has been identified in a handful of Oxford-AstraZeneca recipients in Canada. Here's what to look for.

Source name:

Unique identifier: CP122883921

Legacy Identifier: bc44b143254ad43a18ad3c4655f949f3c

Type: Video

Duration: 2m28s

Dimensions: 1920px × 1080px 75.25 MB

Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE.

Create Date: 5/5/2021 10:01:00 PM

Display aspect ratio: 16:9